XML 144 R135.htm IDEA: XBRL DOCUMENT v3.24.0.1
Parent Company Only Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]      
Net Income (Loss) $ 68,935,000 $ 72,952,000 $ 51,490,000
Depreciation, amortization and accretion, net 14,904,000 15,060,000 14,449,000
Increase in other assets (20,562,000) (19,537,000) (13,719,000)
Increase (decrease) in other liabilities (1,674,000) 3,318,000 5,463,000
Net cash provided by operating activities 72,417,000 65,824,000 69,596,000
Net cash provided by (used in) investing activities 474,380,000 (178,688,000) (482,499,000)
Proceeds from issuance of common stock 1,004,000 1,244,000 1,937,000
Payment to repurchase common stock (465,000) (340,000) (326,000)
Direct expenses related to capital transactions 0 (29,000) (206,000)
Dividends paid on common stock (19,557,000) (17,830,000) (14,721,000)
Net cash provided by (used in) financing activities (556,166,000) 96,695,000 164,224,000
Decrease in cash and cash equivalents (9,369,000) (16,169,000) (248,679,000)
Cash and cash equivalents at beginning of period 152,433,000 168,602,000 417,281,000
Cash and cash equivalents at end of period 143,064,000 152,433,000 168,602,000
Parent Company [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net Income (Loss) 68,935,000 72,952,000 51,490,000
Depreciation, amortization and accretion, net 265,000 218,000 350,000
Dividends received from subsidiary 51,213,000 34,040,000 28,075,000
Equity in undistributed earnings of subsidiaries (26,374,000) (44,811,000) (30,380,000)
Increase in other assets (49,606,000) (208,359,000) (206,880,000)
Increase (decrease) in other liabilities 1,526,000 (146,000) 1,760,000
Net cash provided by operating activities 45,959,000 (146,106,000) (155,585,000)
Net cash from (used in) business acquisition (41,827,000) 67,323,000 30,968,000
Net cash provided by (used in) investing activities (41,827,000) 67,323,000 30,968,000
Proceeds from issuance of common stock 1,004,000 93,415,000 46,128,000
Payment to repurchase common stock (465,000) (340,000) (326,000)
Direct expenses related to capital transactions 0 (29,000) (206,000)
Dividends paid on common stock (19,557,000) (17,830,000) (14,721,000)
Net cash provided by (used in) financing activities (19,018,000) 75,216,000 30,875,000
Decrease in cash and cash equivalents (14,886,000) (3,567,000) (93,742,000)
Cash and cash equivalents at beginning of period 24,854,000 28,421,000 122,163,000
Cash and cash equivalents at end of period $ 9,968,000 $ 24,854,000 $ 28,421,000